← Back to Search

Behavioral Intervention

TeleHealth Resources for Alcoholism (THRIVE Trial)

N/A

Recruiting

Led By Katie Witkiewitz

Research Sponsored by University of New Mexico

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years old

Be older than 18 years old

Must not have

Current symptoms of psychosis or mania

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to three year follow-up period

Awards & highlights

No Placebo-Only Group

Summary

This trial will study how mindfulness-based relapse prevention via video helps people with alcohol use disorder reduce or stop drinking. It will also look at how widely it's adopted and how it supports long-term recovery in underserved areas.

Who is the study for?

This trial is for adults over 18 with alcohol use disorder (AUD) who have tried to reduce or stop drinking in the last 3 months. Participants must be willing to use a smart device, understand English or Spanish, and not require inpatient detoxification. They should also not have severe mental health issues like psychosis or mania.

What is being tested?

The THRIVE study tests if mindfulness-based relapse prevention via video conferencing helps long-term recovery from AUD compared to online support groups. It looks at how well this method works across communities, including underserved areas.

What are the potential side effects?

Since the interventions involve non-medical treatments such as online support and mindfulness training, typical medical side effects are not expected; however, participants may experience emotional discomfort when discussing their experiences with alcohol.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently experiencing symptoms of psychosis or mania.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to three year follow-up period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to three year follow-up period

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to three year follow-up period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Recovery from AUD

Secondary study objectives

Addiction Cycle - Executive Function Scale

Addiction Cycle - Incentive Salience Scale

Addiction Cycle - Negative Emotionality Scale

+11 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mindfulness-based relapse preventionExperimental Treatment1 Intervention

The MBRP condition will be based on an existing rolling group treatment manual, which consists of eight 60-minute sessions. Each session will begin with a brief mindfulness practice and a discussion of "what is mindfulness?" and the role mindfulness may play in recovery. The themes are repeated every eight sessions, but in every session the participant is bringing a new direct moment experience to the practices in that session. The groups will also consist of people in various stages of recovery and familiarity with the material, which can make for richer discussions of the material led by the group members themselves. Participants who are randomized to receive rolling MBRP treatment will also have access to the Thrive Recovery smart phone app, which includes audio-guided MBRP meditations for participants to practice in daily life.

Group II: Referral to online mutual support groupsActive Control1 Intervention

The referral group will consist of a brief 1:1 meeting with a research team member who will provide an orientation to online mutual support and discuss the SMART Recovery, Alcoholics Anonymous (AA), and other virtual meeting options and to discuss how to access mutual support via these platforms. Individuals will also have an opportunity to review the process of attending online groups, and will discuss technology issues that might arise during groups. The session will be 20-30 minutes in length.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mindfulness-based relapse prevention

2015

N/A

~20

0 / 2Eligibility criteria met